Rapport Therapeutics, Inc. RAPP Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s accrued liabilities, current?
- Rapport Therapeutics, Inc. (RAPP) reported accrued liabilities, current of $8.72M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s accrued liabilities, current changed year-over-year?
- Rapport Therapeutics, Inc.'s accrued liabilities, current increased by 39.8% year-over-year, from $6.24M to $8.72M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s accrued liabilities, current?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s accrued liabilities, current has grown at a 46.6% compound annual growth rate (CAGR), from $5.63M to $12.1M.